We are live on
!
Find out more
Fate Therapeutics
FATE
FATE
74 hedge funds and large institutions have $101M invested in Fate Therapeutics in 2017 Q3 according to their latest regulatory filings, with 19 funds opening new positions, 18 increasing their positions, 22 reducing their positions, and 5 closing their positions.
New
Increased
Maintained
Reduced
Closed
280% more first-time investments, than exits
New positions opened: 19 | Existing positions closed: 5
23% more funds holding
Funds holding: 60 → 74 (+14)
17% more capital invested
Capital invested by funds: $86.2M → $101M (+$14.4M)
0% more funds holding in top 10
Funds holding in top 10: 1 → 1 (0)
2.93% less ownership
Funds ownership: 64.28% → 61.35% (-2.9%)
18% less repeat investments, than reductions
Existing positions increased: 18 | Existing positions reduced: 22
100% less call options, than puts
Call options by funds: $0 | Put options by funds: $1K
Holders
74
Holders Change
+14
Holders Change %
+23.33%
% of All Funds
1.84%
Holding in Top 10
1
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.02%
New
19
Increased
18
Reduced
22
Closed
5
Calls
–
Puts
$1K
Net Calls
-$1K
Net Calls Change
-$1K
Top Buyers
Top Sellers
| 1 |
KCM
Kingdon Capital Management
New York
|
-$2.6M |
| 2 |
Fidelity Investments
Boston,
Massachusetts
|
-$1.28M |
| 3 |
BI
BVF Inc
San Francisco,
California
|
-$1.27M |
| 4 |
EC
EcoR1 Capital
San Francisco,
California
|
-$933K |
| 5 |
Renaissance Technologies
New York
|
-$302K |
